The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?
Open accessAbstract
Background: Patients with inflammatory bowel disease (IBD) are thought to be at increased risk of venous thromboembolism (TE). However, the extent of this risk is not known. Furthermore, it is not known if this risk is specific for IBD or if it is shared by other chronic inflammatory diseases or other chronic bowel diseases. Aims: To compare the risk of TE in patients with IBD, rheumatoid arthritis, and coeliac disease with matched control subjects. Patients and methods: Study subjects answered a questionnaire assessing the history of TE, any cases of which had to be confirmed radiologically. A total of 618 patients with IBD, 243 with rheumatoid arthritis, 207 with coeliac disease, and 707 control subjects were consecutively included. All three patient groups were compared with control subjects matched to the respective group by age and sex. Results: Thirty eight IBD patients (6.2%) had suffered TE. This was significantly higher compared with the matched control population with only 10 cases reported (1.6%) (p<0.001; odds ratio (OR) 3.6 (95% confidence interval (CI) 1.7–7.8)). Five patients with rheumatoid arthritis (2.1%) had suffered TE compared with six subjects (2.5%) in the control population matched to patients with rheumatoid arthritis (NS; OR 0.7 (95% CI 0.2–2.9)). TE had occurred in two patients with coeliac disease (1%) compared with four subjects (1.9%) in the control population matched to the coeliac disease group (NS; OR 0.4 (95% CI 0.1–2.5)). In 60% of TE cases in the IBD group, at least one IBD specific factor (active disease, stenosis, fistula, abscess) was present at the time TE occurred. Conclusions: IBD is a risk factor for TE. It seems that TE is a specific feature of IBD as neither rheumatoid arthritis, another chronic inflammatory disease, nor coeliac disease, another chronic bowel disease, had an increased risk of TE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY
Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,959
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.585 · Cited by 2,660
(1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.8.909 · Cited by 1,307
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
den Heijer, M., Koster, T., Blom, H. J., Bos, G. M. J., Briët, E., Reitsma, P. H., Vandenbroucke, J. P., & Rosendaal, F. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341203 · Cited by 1,044
Course and prognosis of ulcerative colitis: Part III Complications
Edwards, F. C., & Truelove, S. C. (1964) · Gut · doi:10.1136/gut.5.1.1 · Cited by 687
Vascular Complications of Inflammatory Bowel Disease
TALBOT, R. W., HEPPELL, J., DOZOIS, R. R., & BEART, R. W. (1986) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65200-8 · Cited by 630
Revised criteria for diagnosis of coeliac disease
Walker‐Smith, J. A., Guandalini, S., Schmitz, J., Shmerling, D. H., & Visakorpi, J. K. (1990) · Cited by 599
Blanchard, J., Houston, D., Wajda, A., & Bernstein, C. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615600 · Cited by 577
Severe Pulmonary Embolism Associated with Air Travel
Lapostolle, F., Surget, V., Borron, S. W., Desmaizières, M., Sordelet, D., Lapandry, C., Cupa, M., & Adnet, F. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010378 · Cited by 445
Wållberg‐Jonsson, S., Johansson, H., Ohman, M. L., & Rantapää‐Dahlqvist, S. (1999) · PubMed · Cited by 409
Transient changes of serum lipoprotein(a) as an acute phase protein
Maeda, S., Abe, A., Seishima, M., Makino, K., Noma, A., & Kawade, M. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90218-9 · Cited by 365
Hansson, P.-O., Eriksson, H., Welin, L., Svärdsudd, K., & Wilhelmsen, L. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1886 · Cited by 310
A Critical Review of Epidemiological Studies in Inflammatory Bowel Disease
Farrokhyar, F., Swarbrick, E. T., & Irvine, E. J. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520150218002 · Cited by 243
Cybulsky, M. I., Chan, M. K. W., & Movat, H. Z. (1989) · Pathology Reviews · 1989 · doi:10.1007/978-1-4612-4502-5_6 · Cited by 229
Platelets circulate in an activated state in inflammatory bowel disease
Collins, C. E., Cahill, M. R., Newland, A. C., & Rampton, D. S. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90741-2 · Cited by 227
Significance of systemic endotoxaemia in inflammatory bowel disease.
Gardiner, K. R., Halliday, M. I., Barclay, G. R., Milne, L., Brown, D., Stephens, S., Maxwell, R. J., & Rowlands, B. J. (1995) · Gut · doi:10.1136/gut.36.6.897 · Cited by 227
The importance of diagnostic accuracy in colonic inflammatory bowel disease
Farmer, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01992-4 · Cited by 172
Sample size calculations for clinical pharmacology studies
Stolley, P. D., & Strom, B. L. (1986) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1986.85 · Cited by 165
Souto, J. C., Martínez, E., Roca, M., Mateo, J., Pujol, J., González, D., & Fontcuberta, J. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02208650 · Cited by 159
Thrombotic vascular risk factors in inflammatory bowel disease.
Hudson, M., Chitolie, A., Hutton, R. A., Smith, M. S., Pounder, R. E., & Wakefield, A. J. (1996) · Gut · doi:10.1136/gut.38.5.733 · Cited by 144
Lennard-Jones, J. E., & Shivananda, S. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199704000-00007 · Cited by 135
Inflammatory Bowel Disease Promotes Venous Thrombosis Earlier in Life
Grip, O., Svensson, P. J., & Lindgren, S. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750023589 · Cited by 122
Wellmann, W., Fink, P. C., Benner, F., & Schmidt, F. W. (1986) · Gut · doi:10.1136/gut.27.7.814 · Cited by 110
Homocysteine in Inflammatory Bowel Disease: A Risk Factor for Thromboembolic Complications?
Oldenburg, B., Fijnheer, R., van der Griend, R., et al. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03193.x · Cited by 110
Anti-Cardiolipin Antibodies in Patients with Inflammatory Bowel Disease
Aichbichler, B. W., Petritsch, W., Reicht, G., Wenzl, H., Eherer, A. J., Hinterleitner, T. A., Auer‐Grumbach, P., & Krejs, G. J. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026646816672 · Cited by 90
Guédon, C., Cam-Duche, V. L., Lalaude, O., Ménard, J.-F., Lerebours, E., & Borg, J. Y. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03797.x · Cited by 87
Anti-cardiolipin and Anti-β2-glycoprotein I Antibodies in Patients with Inflammatory Bowel Disease
Κoutroubakis, I. E., Petinaki, E. A., Anagnostopoulou, E., Kritikos, H. D., Mouzas, I., Kouroumalis, E., & Manousos, O. N. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026602803622 · Cited by 84
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
Cattaneo, M., Martinelli, I., & Mannucci, P. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609263351313 · Cited by 74
Silverberg, M. S., Daly, M. J., Moskovitz, D. N., Rioux, J. D., McLeod, R. S., Cohen, Z., Greenberg, G. R., Hudson, T., Siminovitch, K. A., & Steinhart, A. H. (2001) · Gut · doi:10.1136/gut.49.6.773 · Cited by 57
Heinemann, L. A. J., Lewis, M. A., Assmann, A., & Thiel, C. (2002) · Contraception · doi:10.1016/s0010-7824(01)00309-2 · Cited by 43
Disturbed fibrinolysis in patients with inflammatory bowel disease.
Robertson, D. A. (1989) · Gut · doi:10.1136/gut.30.9.1300 · Cited by 29
Cited by
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Van Assche, G., Dignass, A., Reinisch, W., van der Woude, C. J., Sturm, A., De Vos, M., Guslandi, M., Oldenburg, B., Dotan, I., Marteau, P., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.09.009 · Cited by 894
Self-citationGrainge, M. J., West, J., & Card, T. R. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61963-2 · Cited by 730
A comprehensive review and update on ulcerative colitis,
Gajendran, M., Loganathan, P., Jimenez, G., Catinella, A. P., Ng, N., Umapathy, C., Ziade, N., & Hashash, J. G. (2019) · Disease-a-Month · doi:10.1016/j.disamonth.2019.02.004 · Cited by 638
Ritis, K., Doumas, M., Mastellos, D., Micheli, A., Giaglis, S., Magotti, P., Rafail, S., Kartalis, G., Sideras, P., & Lambris, J. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4794 · Cited by 489
Metadata
- Authors
- Miehsler, W., Reinisch, W., Valic, E., Osterode, W., Tillinger, W., Feichtenschlager, T., Grisar, J., Machold, K., Scholz, S., Vogelsang, H., & Novacek, G.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2004-03-11
- Volume
- 53
- Issue
- 4
- Pages
- 542-548
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2165714472
- Cited by
- 479
- References
- 33
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.